Literature DB >> 9434772

Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells.

D J Withers1, D M Ouwens, B T Nave, G C van der Zon, C M Alarcon, M E Cardenas, J Heitman, J A Maassen, P R Shepherd.   

Abstract

The role of the mammalian target of rapamycin (mTOR) was investigated in insulin responsive cell lines. mTOR was expressed at high levels in insulin responsive cell types and in 3T3-L1 cells mTOR expression levels increased dramatically as cells differentiated from fibroblasts into insulin responsive adipocytes. mTOR localized to membrane fractions in all cells tested and in 3T3-L1 adipocytes mTOR was specifically localized to microsomal membranes. Protein kinase activity directed towards mTOR was tightly associated with mTOR immunoprecipitates and this kinase activity was inhibited by FKBP12-rapamycin indicating it was due to an autokinase activity present in mTOR. The mTOR autokinase and the protein kinase activity of the p110 alpha isoform of PI 3-kinase shared several notable similarities; (a) both were maximally active in the presence of Mn2+ but also showed significant activity in the presence of Mg2+ (b) neither were inhibited by the presence of non-ionic detergent and (c) both were inhibited by wortmannin and LY294002, known inhibitors of the PI 3-kinase lipid kinase activity. These data taken together indicate the autokinase activity lay in the PI 3-kinase homology domain. In summary mTOR is a membrane anchored protein kinase that is active in conditions encountered in vivo and the fact it is highly expressed in insulin responsive cell types is consistent with a role in insulin signalling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434772     DOI: 10.1006/bbrc.1997.7878

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Intrahippocampal wortmannin infusion enhances long-term spatial and contextual memories.

Authors:  Pramod K Dash; Sara A Mach; Sonja Blum; Anthony N Moore
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

3.  A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda.

Authors:  Thorsten Fritzius; Gabriela Burkard; Elvira Haas; Jochen Heinrich; Marc Schweneker; Magnus Bosse; Sven Zimmermann; Alexander D Frey; Antje Caelers; Andre S Bachmann; Karin Moelling
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

4.  Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.

Authors:  A Takano; I Usui; T Haruta; J Kawahara; T Uno; M Iwata; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.

Authors:  Maristella De Cicco; Lech-G Milroy; Sonja A Dames
Journal:  Protein Sci       Date:  2017-10-30       Impact factor: 6.725

6.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.

Authors:  D M Ouwens; C Boer; M Fodor; P de Galan; R J Heine; J A Maassen; M Diamant
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

7.  Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.

Authors:  C M Alarcon; J Heitman; M E Cardenas
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

8.  The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.

Authors:  Jae H Choi; Paula G Bertram; Ryan Drenan; John Carvalho; Heather H Zhou; X F Steven Zheng
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

9.  Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines.

Authors:  Michael S Kent; Cameron J Collins; Fang Ye
Journal:  Am J Vet Res       Date:  2009-02       Impact factor: 1.156

10.  Receptor internalization in yeast requires the Tor2-Rho1 signaling pathway.

Authors:  Amy K A deHart; Joshua D Schnell; Damian A Allen; Ju-Yun Tsai; Linda Hicke
Journal:  Mol Biol Cell       Date:  2003-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.